ATTENUATION OF SCH-23390-INDUCED ALTERATION OF STRIATAL DOPAMINE D1 RECEPTOR ONTOGENY BY PROLYL-LEUCYL-GLYCINAMIDE IN THE RAT

被引：7
作者：
KOSTRZEWA, RM
SALEH, MI
机构：
来源：
NEUROPHARMACOLOGY | 1989年 / 28卷 / 08期
关键词：
D O I：
10.1016/0028-3908(89)90171-8
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：805 / 810
页数：6
相关论文
共 50 条
[41]   STRIATAL D1 DOPAMINE RECEPTOR DENSITY FLUCTUATES DURING THE RAT ESTROUS-CYCLE [J].
LEVESQUE, D ;
GAGNON, S ;
DIPAOLO, T .
NEUROSCIENCE LETTERS, 1989, 98 (03) :345-350
[42]   IDENTIFICATION OF D1 DOPAMINE-RECEPTORS IN RAT RENAL CORTICAL HOMOGENATES USING [H-3]SCH23390 [J].
SETH, A ;
DAWSON, R .
FASEB JOURNAL, 1988, 2 (04) :A793-A793
[43]   EFFECTS OF ESTRADIOL ON THE ONTOGENY OF STRIATAL DOPAMINE D1 AND D2 RECEPTOR-SITES IN MALE AND FEMALE RATS [J].
FERRETTI, C ;
BLENGIO, M ;
VIGNA, I ;
GHI, P ;
GENAZZANI, E .
BRAIN RESEARCH, 1992, 571 (02) :212-217
[44]   Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons [J].
Iwakura, Yuriko ;
Nawa, Hiroyuki ;
Sora, Ichiro ;
Chao, Moses V. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (23) :15799-15806
[45]   SLEEP-DEPRIVATION INCREASES DOPAMINE D1 RECEPTOR ANTAGONIST [H-3] SCH 23390 BINDING AND DOPAMINE-STIMULATED ADENYLATE-CYCLASE IN THE RAT LIMBIC SYSTEM [J].
DEMONTIS, MG ;
FADDA, P ;
DEVOTO, P ;
MARTELLOTTA, MC ;
FRATTA, W .
NEUROSCIENCE LETTERS, 1990, 117 (1-2) :224-227
[46]   CHRONIC TREATMENT WITH SCH-23390, A SELECTIVE DOPAMINE D-1 RECEPTOR ANTAGONIST, DECREASES DOPAMINE METABOLISM IN RAT CAUDATE-NUCLEUS [J].
KOULU, M ;
LAPPALAINEN, J ;
PESONEN, U ;
HIETALA, J ;
SYVALAHTI, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (03) :313-316
[47]   Dopamine D1 receptor availability in Gilles de la Tourette syndrome measured by [11C]SCH23390 PET [J].
Rullmann, M. ;
Gkotsoulias, D. ;
Schmitt, S. ;
Fremer, C. ;
Klages, C. ;
Hartung, K. ;
Bujanow, A. ;
Zientek, F. ;
Messerschmidt, K. ;
Patt, M. ;
Sabri, O. ;
Mueller-Vahl, K. ;
Moeller, H. ;
Barthel, H. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) :S244-S244
[48]   The dopamine D1 receptor availability is reduced in Gilles de la Tourette syndrome: A C-11-SCH23390 PET study [J].
Messerschmidt, Konstantin ;
Rullmann, Michael ;
Gkotsoulias, Dimitrios ;
Schmitt, Simon ;
Fremer, Carolin ;
Klages, Carolin ;
Hartung, Kathrin ;
Bujanow, Anna ;
Zientek, Franziska ;
Patt, Marianne ;
Sabri, Osama ;
Mueller-Vahl, Kirsten ;
Moeller, Harald ;
Barthel, Henryk .
JOURNAL OF NUCLEAR MEDICINE, 2023, 64
[49]   CHRONIC TREATMENT WITH SCH-23390 INCREASES THE PRODUCTION-RATE OF DOPAMINE-D(1) RECEPTORS IN THE NIGRO-STRIATAL SYSTEM OF THE RAT [J].
GIORGI, O ;
PIBIRI, MG ;
LOI, R ;
CORDA, MG .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 245 (02) :139-145
[50]   COMP 161-Evaluation of density functionals, semiempirical methods, SCC-DFTB and molecular mechanics force fields for prolyl-leucyl-glycinamide (PLG) analogs designed as dopamine D2 receptor modulators [J].
Amin, Elizabeth A. ;
Wood, Richard J. ;
Johnson, Rodney L. ;
Young-Dixon, Breden J. .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
12345